Sandgaard Capital

Big News from Zynex Monitoring Solutions!

Zynex has officially submitted its FDA 510(k) application for the NiCO™ laser-based pulse oximeter — a next-gen innovation that could redefine accuracy in oxygen monitoring.

🔬 Unlike traditional red-infrared tech, NiCO™ uses laser light to potentially detect oxygen saturation and pulse rate more reliably — especially in patients with poor circulation, dark skin pigmentation, or low perfusion.

Why does this matter?
➡️ Lives depend on precision.
➡️ Millions of patients are monitored daily with oximeters.
➡️ Greater accuracy = better outcomes in critical care, surgery, and recovery.

This marks a bold step forward in Zynex’s commitment to patient-first innovation. 🚀 Zynex is not just treating pain — they are pushing boundaries in non-invasive monitoring.

📈 Stay tuned as we await feedback from the FDA. If cleared, NiCO™ could become a game-changer in clinical settings across the country.

Click the following link to learn more: https://www.proactiveinvestors.co.uk/companies/news/1071056/zynex-submits-fda-application-for-nico-laser-pulse-oximeter-1071056.html

Zynex submits FDA application for NiCO laser pulse oximeter Zynex Inc (NASDAQ:ZYXI) announced it has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its NiCO Noninvasive CO-Oximeter...

💥 Fighting pain without pills! 💪

Zynex Medical’s Stephen Fox shares how their flagship device, NexWave, is changing the game in pain management ✨

✅ Noninvasive
✅ Non-addictive
✅ At-home relief

With three (3) powerful therapies (TENS, IFC, NMES), NexWave helps patients recover safely without side effects — no opioids needed. 🙅‍♂️💊

📢 Nearly 300 reps across the U.S. are educating providers and pushing back against the opioid crisis.

“We’re united by one mission: better, safer pain relief,” says Fox 💙

Watch the interview and read the article here to learn more: https://www.proactiveinvestors.com/companies/news/1069097/zynex-medical-champions-noninvasive-non-addictive-pain-management-with-nexwave.html